1. Home
  2. MRUS vs PRGS Comparison

MRUS vs PRGS Comparison

Compare MRUS & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • PRGS
  • Stock Information
  • Founded
  • MRUS 2003
  • PRGS 1981
  • Country
  • MRUS Netherlands
  • PRGS United States
  • Employees
  • MRUS N/A
  • PRGS N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • PRGS Computer Software: Prepackaged Software
  • Sector
  • MRUS Health Care
  • PRGS Technology
  • Exchange
  • MRUS Nasdaq
  • PRGS Nasdaq
  • Market Cap
  • MRUS 2.7B
  • PRGS 2.4B
  • IPO Year
  • MRUS 2016
  • PRGS 1991
  • Fundamental
  • Price
  • MRUS $40.90
  • PRGS $60.90
  • Analyst Decision
  • MRUS Strong Buy
  • PRGS Buy
  • Analyst Count
  • MRUS 14
  • PRGS 7
  • Target Price
  • MRUS $87.00
  • PRGS $73.71
  • AVG Volume (30 Days)
  • MRUS 770.0K
  • PRGS 447.0K
  • Earning Date
  • MRUS 05-07-2025
  • PRGS 06-24-2025
  • Dividend Yield
  • MRUS N/A
  • PRGS 0.57%
  • EPS Growth
  • MRUS N/A
  • PRGS N/A
  • EPS
  • MRUS N/A
  • PRGS 1.27
  • Revenue
  • MRUS $54,732,000.00
  • PRGS $806,739,000.00
  • Revenue This Year
  • MRUS $26.81
  • PRGS $30.62
  • Revenue Next Year
  • MRUS $23.85
  • PRGS $2.94
  • P/E Ratio
  • MRUS N/A
  • PRGS $48.30
  • Revenue Growth
  • MRUS 42.77
  • PRGS 12.85
  • 52 Week Low
  • MRUS $33.19
  • PRGS $48.00
  • 52 Week High
  • MRUS $61.61
  • PRGS $70.56
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 45.06
  • PRGS 61.35
  • Support Level
  • MRUS $37.92
  • PRGS $60.04
  • Resistance Level
  • MRUS $46.36
  • PRGS $62.24
  • Average True Range (ATR)
  • MRUS 2.58
  • PRGS 1.12
  • MACD
  • MRUS -0.27
  • PRGS 0.20
  • Stochastic Oscillator
  • MRUS 35.31
  • PRGS 81.05

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About PRGS Progress Software Corporation (DE)

Progress Software Corporation provides software operate in one operating segment: software products for the development, deployment, and management of responsible, AI-powered applications and digital experiences. Following are products: Chef, Corticon, Data Direct, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, WhatsUp Gold. Geographical regions include United States, Canada, EMEA, Latin America, and Asia Pacific.

Share on Social Networks: